An international full-service integrated health agency, JPA Health, has announced that it has acquired the award-winning medical communications company, BioCentric, Inc. Leading pharmaceutical firms have come to rely on BioCentric for scientific platforms for pipeline product candidates, clinical trial acceleration and HCP engagement.
As the medical communications and learning experiences division of JPA Health, BioCentric will use its innovative serious games and gamification strategy to improve engagements, gather insightful data and promote constructive behavior change. Sherine Aly, who established BioCentric in 2001, will remain in charge of the department and make sure customers get top-notch scientific communication services. BioCentric maintains offices in Lausanne, Switzerland and Collingswood, New Jersey.
“We are thrilled to welcome BioCentric into the growing JPA Health family,” said Carrie Jones, CEO of JPA Health. “This acquisition is a great union, bringing together BioCentric’s medical prowess with JPA’s deeply rooted expertise across marketing, patient advocacy and corporate communications. Our clients will benefit from a fully integrated agency that can deliver unparalleled solutions to help them achieve their goals efficiently and effectively.”
The acquisition expands the agency’s capabilities in Natural Language Processing, Artificial Intelligence, and Predictive Analytics. It comes after JPA Health purchased True North Solutions in September 2023. JPA Health is advancing its goal of offering comprehensive, data-driven and high-impact services to clients in the life sciences, public health, one health and federal government sectors with the merger of True North Solutions and BioCentric.
With offices in the US and Europe, the merged agency employs more than 120 people and provides a synergistic range of services, such as corporate communications, brand marketing, patient involvement and scientific storytelling. The foundation of the integration is the common goal and values of both organizations, which are dedicated to advancing medical research and enhancing patient outcomes.
Read More : https://thecioconnect.com/